Amgen Biosimilars are backed by our four decades of experience in the research, development, manufacturing, and supply of innovator biologics.
Your source for biosimilars information.Learn more
At Amgen, we are proven innovators in a field that’s constantly accelerating. We are inspired every day to engineer robust and differentiated therapeutics.
18 US FDA approval since 1980,
and 4 biosimilar medicines
13EMA approval since 2001,
and 2 biosimilar medicines
31innovator products in various stages of clinical development
our portfolio of biosimilar medicines*
As of August 7, 2019 *Numbers shown are global numbers